Disclosure of acquisition of 1000000 equity shares by Cadamba Solutions Private Limited at an issue price of Rs. 1610 on preferential issue basis
FUNDRAISE
▲ Positive Development
LOW RISK
📅 Filed on BSE: 20 Apr 2026, 06:35 PM IST · BSE ID: 63fc5f9c-ece2-4259-92cb-a7615f20a5ba
View Original BSE Filing (PDF)
💡
In Simple Terms
A promoter group company of Neogen Chemicals invested Rs. 161 Crore to buy 10 lakh shares, becoming a 3.65% shareholder.
🤖 AI Summary
- Cadamba Solutions acquired 10,00,000 equity shares of Neogen Chemicals for Rs. 1,61,00,00,000 at Rs. 1,610 per share
- Preferential allotment completed April 18, 2026; Cadamba stake rises from nil to 3.65% post-allotment
- Cadamba Solutions is promoter group member with no prior shareholding in Neogen
- Company paid-up capital increased from Rs. 26,38,16,740 to Rs. 27,38,16,740 via equity issuance
- Disclosure filed under SEBI Takeover Regulations 29(2); no persons acting in concert with acquirer
🔢 Key Numbers — exact figures from BSE filing, not rounded
Investment amount by Cadamba Solutions
Rs. 1,61,00,00,000
Shares acquired
10,00,000 equity shares
Issue price per share
Rs. 1,610 (face value Rs. 10 + premium Rs. 1,600)
Cadamba stake post-allotment
3.65% of paid-up capital
Pre-allotment paid-up capital
Rs. 26,38,16,740
Post-allotment paid-up capital
Rs. 27,38,16,740
Allotment date
April 18, 2026
🏢 How This Affects the Company
Fresh equity capital of Rs. 1,61,00,00,000 strengthens the company's balance sheet and provides funds for operations or growth initiatives without increasing debt.
Paid-up equity capital expanded by Rs. 1,00,00,000. Cash inflow of Rs. 1,61,00,00,000 increases liquidity. Post-allotment paid-up capital stands at Rs. 27,38,16,740 across 2,73,81,674 shares.
Dilution of existing shareholders' ownership percentage, though concentrated within promoter group. No new leverage incurred.
👥 What This Means For Shareholders
✅
Action Required
Existing shareholders should note their ownership percentage has been diluted by this equity issuance; no action required unless reviewing portfolio impact.
👤
Who Is Affected
All non-promoter shareholders experience ownership dilution. Pre-allotment paid-up capital was Rs. 26,38,16,740 (2,63,81,674 shares); post-allotment it is Rs. 27,38,16,740 (2,73,81,674 shares), reducing each existing shareholder's pro-rata stake.
🔍
Management Signal
Promoter group's fresh Rs. 161 Crore investment signals confidence in company's growth prospects and intent to retain control.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Quarterly shareholding disclosure (Reg 31) — confirm Cadamba stake remains at 3.65% in next quarterly filing
Future dividend announcements — track if capital-raising translates to improved profitability or returns
Next financial results — monitor cash deployment and return on fresh equity capital raised
LOW RISK
Preferential allotment to promoter group member is standard practice. No acquisition debt, no payment default risk, clean regulatory disclosure.
💡 Investor Takeaway
Cadamba Solutions, a promoter group entity, invested Rs. 1,61,00,00,000 to acquire 10,00,000 shares at Rs. 1,610 per share on preferential basis, completed April 18, 2026. Cadamba's stake post-allotment is 3.65% of paid-up capital. This is pure equity funding with no debt incurred, though non-promoter shareholding is diluted proportionally.
⚖️ Strengths & Concerns
✅ Positives
- Strong promoter backing: Rs. 1,61,00,00,000 fresh equity infusion strengthens financial position without debt.
- Clean acquisition structure: Single acquirer, no persons acting in concert, transparent shareholding disclosure.
⚠️ Concerns
- Existing shareholder dilution: Non-promoter shareholders' ownership percentage diluted by this preferential allotment.
- Paid-up capital increase of only Rs. 1,00,00,000 face value for Rs. 1,61,00,00,000 investment shows heavy premium pricing.
📅 Company Track Record
Neogen Chemicals is incorporated in 1989 (CIN L24200MH1989PLC050919). Cadamba Solutions Private Limited was incorporated in 2025 (CIN U82990MH2025PTC462933), making it a newly-formed promoter entity. This is the first equity acquisition by Cadamba in Neogen as per filings available.
Based on publicly available historical data. For context only.